🔸 Revenue: $13.4B 🔸 Adj. EPS: $0.91 vs. $0.88 est. 🔸 Unit case volume: +5% vs. +2.98% est. 🔸 Price/mix: +1% vs. +1.99% est. 🔸 Organic revenue: +7% vs. +4.3% est. 🔸 Concentrate sales: +7% vs. +2.53% est. 🔸 Operating margin: 32.9% vs. 32.6% est. 🔸 FY EPS growth raised to at least 11% from 9–10%.